Addictive disorders, psychiatric symptoms, and potentially traumatic events in individuals with disabilities

by Rodrigo Marín-Navarrete, Ricardo Sánchez-Domínguez, Alejandro Pérez-López, Ricardo Saracco-Alvarez
Published 2022-10-01

Clinical and Functional Differences Between Mexican Youth at Clinical High Risk for Psychosis and With Familial High Risk

by Lourdes Nieto, Tecelli Domínguez-Martínez, Mauricio Rosel-Vales, Ricardo Saracco-Alvarez, Cesar Celada-Borja, María Luisa Rascón-Gasca
Published 2022-07-01

The effect of stressful life events on the risk for psychosis: differences between Mexican at clinical and familial high risk

by Lourdes Nieto, Tecelli Domínguez-Martínez, Laura Navarrete, Mauricio Rosel-Vales, Ricardo Saracco-Álvarez, César Celada-Borja, Maria Luisa Rascón-Gasca, Luis Gerardo Moncayo Samperio
Published 2023-09-01

Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients...

by Samantha Alvarez-Herrera, Mauricio Rosel Vales, Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Yvonne Flores-Medina, José Luis Maldonado-García, Ricardo Saracco-Alvarez, Raúl Escamilla, Lenin Pavón
Published 2024-01-01

Developing an App to Screen for Dual Disorders: A Tool for Improving Treatment Services in Mexico

by Rodrigo Marín-Navarrete, Marta Torrens, Aldebarán Toledo-Fernández, Aldebarán Toledo-Fernández, Joan Ignasi Mestre-Pinto, Ricardo Sánchez-Domínguez, Alejandro Pérez-Lopez, Ricardo Saracco-Alvarez, Eduardo Ángel Madrigal-De León, Nestor Szerman
Published 2021-10-01